Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins
Mafalda Cacciottolo, Justin B Nice, Yujia Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 24

Showing 24 citing articles:

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 141
Exosome as drug delivery system: Current advancements
Vriti Sharma, Chitrangada Das Mukhopadhyay
Extracellular Vesicle (2023) Vol. 3, pp. 100032-100032
Open Access | Times Cited: 50
Multivalent Exosome Based Protein Vaccine: A “Mix and Match” Approach to Epidemic Viruses’ Challenges
Mafalda Cacciottolo, Li‐En Hsieh, Yujia Li, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 258-258
Open Access | Times Cited: 1
Advanced nanoscale delivery systems for mRNA-based vaccines
Maha W. Mobasher, Rais A. Ansari, Ana M. Castejón, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 3, pp. 130558-130558
Closed Access | Times Cited: 8
Edible Plant-Derived Extracellular Vesicles for Oral mRNA Vaccine Delivery
Chiara Gai, Margherita Alba Carlotta Pomatto, Maria Chiara Deregibus, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 200-200
Open Access | Times Cited: 8
Exosome-Mediated Antigen Delivery: Unveiling Novel Strategies in Viral Infection Control and Vaccine Design
Daed El Safadi, Alexandre Mokhtari, Morgane Krejbich, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 280-280
Open Access | Times Cited: 8
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 6
mRNA-based therapeutic strategies for cancer treatment
Thilelli Taibi, Sehyun Cheon, Fabiana Perna, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2819-2834
Closed Access | Times Cited: 5
Engineered dendritic cells-derived exosomes harboring HIV-1 Nefmut-Tat fusion protein and heat shock protein 70: A promising HIV-1 safe vaccine candidate
Parisa Moradi Pordanjani, Azam Bolhassani, Mohammad Hassan Pouriayevali, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132236-132236
Closed Access | Times Cited: 5
Revolutionizing therapeutics: Unleashing the power of extracellular vesicles for disease intervention
S. Ghosal, Bernadett R. Bodnár, Brachyahu Meir Kestecher, et al.
Current Opinion in Physiology (2025), pp. 100815-100815
Open Access
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
Mohammad Mahmoudi Gomari, Taha Ghantabpour, Nima Pourgholamamiji, et al.
Cancer Communications (2025)
Open Access
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
Ankita Saha, Sounak Ghosh Roy, Richa Dwivedi, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 424-424
Open Access
Extracellular Vesicles as a Translational Approach for the Treatment of COVID-19 Disease: An Updated Overview
Enrica Serretiello, Andrea Ballini, Annafrancesca Smimmo, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1976-1976
Open Access | Times Cited: 10
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1345-1345
Open Access | Times Cited: 3
Engineered extracellular vesicles as a next-generation vaccine platform
Mei Lu, Haonan Xing, Xiaoyun Zhao, et al.
Matter (2024) Vol. 7, Iss. 12, pp. 4180-4205
Closed Access | Times Cited: 3
Extracellular vesicles: From large-scale production and engineering to clinical applications
Yuxuan Wang, Jiali Xiong, Kun Ouyang, et al.
Journal of Tissue Engineering (2025) Vol. 16
Open Access
Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants
Mafalda Cacciottolo, Yujia Li, Justin B Nice, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0290046-e0290046
Open Access | Times Cited: 7
Potential of Exosomes as Multifunctional Nanocarriers for Targeted Drug Delivery
Safa Ali Al-Ani, Qiao Ying Lee, Danesha Maheswaran, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 2
Antigen-display exosomes provide adjuvant-free protection against SARS-CoV-2 disease at nanogram levels of spike protein
Chenxu Guo, Jaiprasath Sachithanandham, William Zhong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Proteomic Analysis of Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Systematic Review
Illayaraja Krishnan, Alvin Man Lung Chan, Jia Xian Law, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5340-5340
Open Access | Times Cited: 1
Exosomes as a window of opportunity in hepatocellular carcinoma: Insights from diagnostic to targeted drug delivery
Supriya Gupta, A. Deb, Pranab Behari Mazumder, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 101, pp. 106259-106259
Closed Access | Times Cited: 1
Immunomodulatory properties of Leishmania tarentolae extracellular vesicles containing the Spike protein of SARS-CoV-2
A. Medina, Hamlet Acevedo Ospina, Albert Descoteaux
Frontiers in Parasitology (2024) Vol. 3
Open Access
Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice
Jacklyn R. Hurst, Maedeh Naghibosadat, Patrick Budowski, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0314061-e0314061
Open Access
Multivalent Exosome based protein vaccine: a “mix and match” approach to epidemic viruses’ challenges
Mafalda Cacciottolo, Li‐En Hsieh, Yujia Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
30-Year Development of Inactivated Virus Vaccine in China
Jinrong Shi, Ailin Shen, Yao Cheng, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2721-2721
Open Access
Page 1

Scroll to top